- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 46.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.05M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 39.79M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $93.1M |
| Capex | Q1 2026 · Mar 31, 2025 | $39.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $57.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $53.8M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $111.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $134.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.35B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.33B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.14B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $1.11B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $520.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $574.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.91B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.95B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $486.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $540.7M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.27B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.28B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.58 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.68 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.69 |
| Net Income | Q1 2026 · Mar 31, 2026 | $26.9M |
| Net Income | Q1 2026 · Mar 31, 2025 | $27.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $54.2M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $52.9M |
| Revenue | Q1 2026 · Mar 31, 2026 | $438.9M |
| Revenue | Q1 2026 · Mar 31, 2025 | $315.7M |